- Device
- Vercise Genus DBS System, Vercise Gevia DBS System, Vercise PC DBS System
- Applicant
- Boston Scientific Corp
- PMA number
- P150031
- Supplement
- S068
- Product code
- NHL
- Generic name
- Stimulator, electrical, implanted, for parkinsonian symptoms
- Decision date
- 2024-05-14
- Decision code
- APPR
- Date received
- 2023-12-05
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Approval order statement
- This updated software version only includes the enabling of the DBS Illumina 3D programming feature. All other VNN5 software functions and controls in place for programming the stimulation parameters into the implanted device and for delivering the stimulation via the implanted electrodes remain the same as the previously approved software version. The DBS Illumina 3D programming feature does not replace the need for clinical judgment in determining and finalizing the stimulation parameters that will be clinically effective for the patient, which remains the same as the previously approved software version. The device labeling has been updated with the following changes:- The VNN5 Programming Manual was updated to include the new VNN5 software version number and include instructions specific to the use of the DBS Illumina 3D programming feature.- The Clinician Programmer (CP) Software Installation Guide was updated to remove any specific mention of VNN5, thereby making the instructions more general to installing any software that will be used with the Clinician Programmer.- The DBS Reference Guide was updated to include the new VNN5 software version number and updating the document reference for the new CP Software Installation Guide.- A new Virtual Label was created for VNN5.0.1 to reflect the new software version number.